Gilead's Descovy May Have Problem Getting HIV Prevention Indication In Cisgender Women

 
• By Sue Sutter
  
Aids red ribbon on woman's hand support for World aids day and national HIV/AIDS and aging awareness month concept - Image
Gilead is seeking to expand the labeling of Descovy to include HIV pre-exposure prophylaxsis. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers